<0.15 |
Of limited utility |
Increment of PPV would not be adequate to change patient management |
|
|
Little clinical significance |
0.15 to 0.50 |
Combined use of TCRG and TCRB tests |
Low pretest probability, specificity is more important |
|
Both tests need to be positive for the TCR test to be reported as supporting clonal process |
Maximize PPV and minimize possibility of false positive results (1-PPV) |
0.50 to 0.75 |
Combined use of TCRG and TCRB tests |
Higher pretest probability, sensitivity is more important |
|
At least one test needs to be positive for the TCR test to be reported as supporting clonal process |
Maximize NPV and minimize possibility of false negative results (1-NPV) |
>0.75 |
Of limited utility |
Change of MF probability would not change patient management |
|
|
Little clinical significance |